Cytokine release during CRS—particularly elevated IL-6, IL-1, and IFN-γ—has been shown to compromise the integrity of the blood–brain barrier (BBB), facilitating neuroinflammatory responses [62]. The gene discussed is IFNG; the disease is congenital rubella syndrome.